Literature DB >> 28490996

Cannabidiol in Patients With Intractable Epilepsy Due to TSC: A Possible Medication But Not a Miracle.

Katherine Nickels.   

Abstract

Entities:  

Year:  2017        PMID： 28490996      PMCID： PMC5416866          DOI： 10.5698/1535-7511.17.2.91

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN： 1535-7511            Impact factor:   7.500


× No keyword cloud information.
  9 in total

1.  Epilepsy in children with tuberous sclerosis complex: Chance of remission and response to antiepileptic drugs.

Authors:  Iris E Overwater; Karen Bindels-de Heus; André B Rietman; Leontine W Ten Hoopen; Yvonne Vergouwe; Henriette A Moll; Marie-Claire Y de Wit
Journal:  Epilepsia       Date:  2015-06-04       Impact factor: 5.864

2.  Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial.

Authors:  Orrin Devinsky; Eric Marsh; Daniel Friedman; Elizabeth Thiele; Linda Laux; Joseph Sullivan; Ian Miller; Robert Flamini; Angus Wilfong; Francis Filloux; Matthew Wong; Nicole Tilton; Patricia Bruno; Judith Bluvstein; Julie Hedlund; Rebecca Kamens; Jane Maclean; Srishti Nangia; Nilika Shah Singhal; Carey A Wilson; Anup Patel; Maria Roberta Cilio
Journal:  Lancet Neurol       Date:  2015-12-24       Impact factor: 44.182

Review 3.  The Pharmacological Basis of Cannabis Therapy for Epilepsy.

Authors:  Doodipala Samba Reddy; Victoria M Golub
Journal:  J Pharmacol Exp Ther       Date:  2016-01-19       Impact factor: 4.030

4.  Tuberous sclerosis complex and the ketogenic diet.

Authors:  Eric H Kossoff; Elizabeth A Thiele; Heidi H Pfeifer; Jane R McGrogan; John M Freeman
Journal:  Epilepsia       Date:  2005-10       Impact factor: 5.864

5.  Drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy.

Authors:  Alexandra L Geffrey; Sarah F Pollack; Patricia L Bruno; Elizabeth A Thiele
Journal:  Epilepsia       Date:  2015-06-26       Impact factor: 5.864

6.  Cannabidiol as a new treatment for drug-resistant epilepsy in tuberous sclerosis complex.

Authors:  Evan J Hess; Kirsten A Moody; Alexandra L Geffrey; Sarah F Pollack; Lauren A Skirvin; Patricia L Bruno; Jan L Paolini; Elizabeth A Thiele
Journal:  Epilepsia       Date:  2016-10-03       Impact factor: 5.864

7.  Clobazam therapy of refractory epilepsy in tuberous sclerosis complex.

Authors:  Melanie Jennesson; Agnies M van Eeghen; Paul A Caruso; Jan L Paolini; Elizabeth A Thiele
Journal:  Epilepsy Res       Date:  2012-12-03       Impact factor: 3.045

8.  Vigabatrin for partial-onset seizure treatment in patients with tuberous sclerosis complex.

Authors:  Daniel Friedman; Miles Bogner; Kimberly Parker-Menzer; Orrin Devinsky
Journal:  Epilepsy Behav       Date:  2013-02-11       Impact factor: 2.937

9.  Long-term treatment of epilepsy with everolimus in tuberous sclerosis.

Authors:  Darcy A Krueger; Angus A Wilfong; Maxwell Mays; Christina M Talley; Karen Agricola; Cindy Tudor; Jamie Capal; Katherine Holland-Bouley; David Neal Franz
Journal:  Neurology       Date:  2016-11-04       Impact factor: 9.910
  9 in total
  3 in total

Review 1.  Prospects of Cannabidiol for Easing Status Epilepticus-Induced Epileptogenesis and Related Comorbidities.

Authors:  Dinesh Upadhya; Olagide W Castro; Raghavendra Upadhya; Ashok K Shetty
Journal:  Mol Neurobiol       Date:  2018-01-25       Impact factor: 5.590

Review 2.  Cannabinoids in the Treatment of Epilepsy: Hard Evidence at Last?

Authors:  Emilio Perucca
Journal:  J Epilepsy Res       Date:  2017-12-31

3.  Inhibition of the mechanistic target of rapamycin induces cell survival via MAPK in tuberous sclerosis complex.

Authors:  Yiyang Lu; Erik Y Zhang; Jie Liu; Jane J Yu
Journal:  Orphanet J Rare Dis       Date:  2020-08-17       Impact factor: 4.303
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.